JSS Medical Research Inc

What JSS Medical Research Inc does

JSS Medical Research Inc is a privately held, full-service Contract Research Organization (CRO) headquartered in Saint Laurent, Canada, founded in 1985 and employing 251-500 people. The company provides clinical trial management services to biotechnology and pharmaceutical companies, covering Phase 2 and Phase 3 studies across therapeutic areas including dermatology and critical care pulmonology. Its core service offering includes site coordination, patient recruitment, regulatory compliance oversight, and data collection for drug development programs, with active operations documented in Canada.

Name

JSS Medical Research Inc

Legal name

JSS Medical Research Inc

Website

https://jssresearch.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) / Clinical Trial Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical trial management
• Contract research organization
• Drug development services
• Pharmaceutical research
• Biotech clinical trials

Headquarters

HQ city

Saint Laurent

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Research Services: JSS Medical Research generates revenue by providing contract clinical trial management services to pharmaceutical and biotechnology companies. As a CRO, they manage clinical studies including site selection, patient enrollment oversight, data collection, and regulatory compliance for drug development programs.

Go-to-market motion1 record

Core offering

JSS Medical Research Inc is a contract research organization (CRO) that manages clinical trials on behalf of pharmaceutical and biotechnology companies. Its services span Phase 2 and Phase 3 studies and include site selection, patient enrollment oversight, regulatory compliance, and data collection for drug development programs. The firm operates primarily in Canada and supports international sponsors conducting clinical research in therapeutic areas such as dermatology and pulmonology.

Product overview

JSS Medical Research Inc operates as a Contract Research Organization (CRO) providing clinical research services to pharmaceutical and biotechnology companies. The company offers clinical trial management services including study design support, site coordination, patient recruitment, regulatory affairs management, and data collection. The company has been selected as CRO partner for multiple clinical studies including Phase 2 and Phase 3 trials.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services Contract research organization (CRO) services providing clinical trial management, including site coordination, patient enrollment support, regulatory compliance oversight, and data collection for pharmaceutical and biotechnology company drug development programs.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Edesa BiotechcoreStrategic or Co-development Partner · 20 April 2026JSS Medical Research serves as the primary CRO partner for Edesa Biotech's clinical development programs. The partnership encompasses two significant clinical programs: Phase 2 study of EB06 (monoclonal antibody for vitiligo) targeting enrollment beginning mid-2026 in Canada, and Phase 3 study of paridiprubart for Acute Respiratory Distress Syndrome. JSS manages trial operations including site outreach, patient recruitment, and regulatory compliance following clinical trial application approvals.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Syneos Health: Syneos Health is a global biopharmaceutical services organization providing clinical development and commercialization services — a broad incumbent peer offering overlapping clinical trial management capabilities to JSS.
• IQVIA: IQVIA is the largest global CRO and life sciences services firm, offering full-service clinical trial management across all phases — directly comparable service portfolio to JSS but at vastly greater scale and geographic reach, typically winning Tier 1 sponsor preferred-provider agreements.
• Charles River Laboratories: Charles River is a large contract research organization spanning discovery, safety assessment, and clinical support — comparable CRO services overlap with JSS, particularly in early clinical and biologics, though broader and more vertically integrated.

Direct peers

• Parexel International: Parexel is a major full-service CRO with deep biotech and specialty therapeutic-area expertise (oncology, rare disease) — closely comparable to JSS's specialty CRO positioning and monoclonal antibody trial work.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO focused on complex therapeutic areas (CNS, cardiometabolic, rare disease) — directly comparable mid-tier CRO peer to JSS in specialty clinical trial management.
• Medpace: Medpace is a mid-to-large full-service CRO known for therapeutic specialization (oncology, metabolic, rare disease) and serving small-to-mid biotech — directly comparable business model to JSS Medical Research.
• ICON plc: ICON plc is a top-tier global CRO providing full-service Phase I–IV clinical research, biometrics, and consulting to pharma and biotech — a direct full-service CRO peer to JSS competing for the same multi-program sponsor mandates.

Others

• WCG (WIRB-Copernicus Group): WCG provides clinical trial enabling services including IRB review, site support, and study technology — an ecosystem peer to CROs like JSS, often co-serving the same biotech sponsors alongside clinical operations partners.

Emerging players

• Celerion: Celerion is a clinical research services provider specializing in early-phase and bioequivalence studies for pharma/biotech — comparable contract clinical research services to JSS but tilted toward early-phase rather than JSS's Phase 2/3 specialty.

Regional players

• Pharm-Olam International: Pharm-Olam is a mid-sized CRO with broad emerging-market trial delivery (Latin America, Eastern Europe) — comparable full-service CRO model to JSS but with regional focus areas that overlap with JSS's acquired LATAM Clinical Trials footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JSS Medical Research Inc